Bill Type
Long Title
AN ACT STRENGTHENING THE REGULATORY SYSTEM IN THE COUNTRY TO COMBAT COUNTERFEIT PHARMACEUTICAL PRODUCTS, DECLARING THE MANUFACTURE, IMPORTATION, DISTRIBUTION, SALE OR OFFER FOR SALE, OR POSSESSION OF COUNTERFEIT PHARMACEUTICAL PRODUCTS AS AN OFFENSE INVOLVING ECONOMIC SABOTAGE, PROVIDING FOR THE PROHIBITIONS AND PENALTIES FOR VIOLATIONS AND REVISING FOR THE PURPOSE REPUBLIC ACT NO. 8203 OR THE 'SPECIAL LAW ON COUNTERFEIT DRUGS'
Short Title
COUNTERFEIT PHARMACEUTICAL PRODUCTS PREVENTION ACT
Date filed
April 19, 2021
Scope
Legislative Status
Legislative Status Date
Session Sequence No.
59
Session Type
Document Certification

Committee Details

Primary Committee
Secondary Committee

Legislative History

Entitled:
AN ACT STRENGTHENING THE REGULATORY SYSTEM IN THE COUNTRY TO COMBAT COUNTERFEIT PHARMACEUTICAL PRODUCTS, DECLARING THE MANUFACTURE, IMPORTATION, DISTRIBUTION, SALE OR OFFER FOR SALE, OR POSSESSION OF COUNTERFEIT PHARMACEUTICAL PRODUCTS AS AN OFFENSE INVOLVING ECONOMIC SABOTAGE, PROVIDING FOR THE PROHIBITIONS AND PENALTIES FOR VIOLATIONS AND REVISING FOR THE PURPOSE REPUBLIC ACT NO. 8203 OR THE ‘SPECIAL LAW ON COUNTERFEIT DRUGS’
[ SECOND REGULAR SESSION, 18TH CONGRESS ]
[ 2021 ]
4/19/2021 Introduced by Senator RISA HONTIVEROS;
5/17/2021 Read on First Reading and Referred to the Committees on HEALTH AND DEMOGRAPHY and FINANCE;